![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1532593-30-8
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | ML355 REF: IN-DA00ABKUCAS: 1532593-30-8 | 98% | 49,00 €~567,00 € | Lun 03 Mar 25 |
![]() | ML355 REF: 4Z-K-031056CAS: 1532593-30-8 | - - - | A consultar | Lun 10 Mar 25 |
![]() | ML355 REF: TM-T4347CAS: 1532593-30-8 | 98.2% - 99.26% | 46,00 €~1.468,00 € | Lun 10 Mar 25 |
![]() | ML355 REF: 3D-HLC59330CAS: 1532593-30-8 | Min. 95% | A consultar | Lun 14 Abr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: IN-DA00ABKU
5mg | 49,00 € | ||
10mg | 67,00 € | ||
25mg | 111,00 € | ||
50mg | 186,00 € | ||
100mg | 225,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-K-031056
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
ML355
CAS:1532593-30-8
ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.
Fórmula:
C21H19N3O4S2
Pureza:
98.2% - 99.26%
Forma y color:
Solid
Peso molecular:
441.52
Ref: TM-T4347
1mg | 46,00 € | ||
5mg | 97,00 € | ||
10mg | 160,00 € | ||
25mg | 298,00 € | ||
50mg | 487,00 € | ||
100mg | 747,00 € | ||
200mg | 1.017,00 € | ||
1mL*10mM (DMSO) | 101,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
ML355
CAS:1532593-30-8
ML355 is an antithrombotic agent that inhibits platelet aggregation, which is the first step in …
Fórmula:
C21H19N3O4S2
Pureza:
Min. 95%
Peso molecular:
441.52 g/mol
Ref: 3D-HLC59330
25mg | 1.198,00 € | ||
50mg | 1.666,00 € | ||
100mg | 2.665,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025